New study tests which shoulder pain treatment lasts longer

NCT ID NCT07302490

Symptom relief Sponsor: Nida Koçer Nazlıgül Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two treatments for chronic shoulder pain: a nerve block injection and a radiofrequency ablation procedure. 104 adults with shoulder pain for at least 3 months were treated and followed for 3 months. The goal was to see which treatment provides better and longer-lasting pain relief and improved shoulder function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: pulsed radiofrequency ablation and nerve block injection (lidocaine and corticosteroid)
What this could lead to: If successful, this could show that radiofrequency ablation provides longer-lasting pain relief than a standard nerve block for chronic shoulder pain.
What could go wrong: This is a completed study with 104 participants, so results are limited. The treatments may not work for everyone, and there are risks like temporary numbness or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

104 people

The number who actually took part.

Started

Jul 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults aged 18 to 75 years, male or female. Presence of shoulder pain and/or mobility limitation for at least 3 months. Failure to benefit from medical treatment and exercise-based conservative therapy. Voluntary participation and ability to provide written informed consent for enrollment in the study. Exclusion Criteria: Age younger than 18 years or older than 75 years. Shoulder pain caused by non-shoulder conditions such as cervical radiculopathy or myofascial pain syndrome. Presence of severe chronic respiratory disease. History of intra-articular, peri-articular, or suprascapular nerve injection, or use of physical therapy modalities applied to the affected shoulder within the past 3 months. Diagnosis of fibromyalgia. Presence of complex regional pain syndrome, entrapment neuropathy, or vascular disease affecting the same upper extremity. Coagulopathy or bleeding diathesis. Presence of inflammatory or malignant disease. Severe psychiatric disorder or mental condition impairing cooperation or compliance. Refusal to participate or inability to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic shoulder pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain rotator cuff syndrome shoulder impingement syndrome Shoulder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic shoulder pain Rotator cuff related shoulder pain Shoulder impingement syndrome Suprascapular nerve-related shoulder pain

New study tests which shoulder pain treatment lasts longer

What the study statuses mean